DDB2 and ovarian carcinoma: In addition, other reports have confirmed that the damage-specific DNA binding protein 2 (DDB2) gene, a molecular GGR/NER component that also plays an important role in apoptosis, participates in the sensitivity of platinum-based drugs in ovarian carcinoma cells [46,47].